US

AstraZeneca, a leading pharmaceutical company, has been making notable strides beyond its successful oncology portfolio. Jefferies analyst Peter Welford believes that investors should not overlook the company’s robust pipeline of therapies in the cardio and respiratory space. In fact, Welford recently upgraded the stock from hold to buy and raised the price target on U.S.-listed
0 Comments
The recent announcement by the Federal Reserve regarding their higher-for-longer rate path has raised concerns about the recovery prospects for small cap and international stocks. However, one strategist believes that despite the potential delays, investors should not overlook these assets. This article delves into the performance of small cap and international stocks, the impact of
0 Comments
Electric vehicles are revolutionizing the automotive industry, and investors are keen to participate in this transformative trend. However, traditional electric vehicle exchange-traded funds (ETFs) often lack concentrated exposure to the sector. Defiance ETFs aims to address this gap by offering the Solactive Pure U.S. Electric Vehicle ETF, also known as the Pure EV Index fund.
0 Comments
Recently, five American citizens who had been wrongfully imprisoned in Iran were finally released and have arrived back on U.S. soil. This significant development marks the end of a long and arduous journey for these individuals and their families. Despite the strained relationship between the United States and Iran, the prisoner exchange agreement has allowed
0 Comments
Agility Robotics, the trailblazing robotics company, is making waves in the industry by opening the doors to its state-of-the-art factory, aptly named the “RoboFab,” in Salem, Oregon. This 70,000 square-foot facility is set to revolutionize the production of humanoid robots, marking a significant milestone for the company and the robotics industry as a whole. With
0 Comments